• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎变异株流行期间合并 COVID-19 的患者适应性免疫功能障碍和肾功能受损。

Adaptive immune dysfunction in patients with COVID-19 and impaired kidney function during the omicron surge.

机构信息

Department of Nephrology, Molecular Cell Lab for Kidney Disease, Shanghai Peritoneal Dialysis Research Center, Ren Ji Hospital, Uremia Diagnosis and Treatment Center, Shanghai Jiao Tong University School of Medicine, Shanghai 200127, China; Academy of Integrative Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 201210, China.

Clinical Research Center, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

出版信息

Clin Immunol. 2023 Mar;248:109271. doi: 10.1016/j.clim.2023.109271. Epub 2023 Feb 18.

DOI:10.1016/j.clim.2023.109271
PMID:36806705
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC9938757/
Abstract

BACKGROUND

Little is known about the characteristics of lymphocyte subsets and the association with patient outcomes in COVID-19 with and without impaired kidney function.

METHODS

Lymphocyte subsets were compared in COVID-19 patients with or without kidney dysfunction. The primary outcome was a composite of all-cause mortality or intensive care unit admission. Secondary outcomes included duration of viral shedding, length of hospital stay, and acute kidney injury.

RESULTS

Lymphocyte subset cell counts demonstrated the lowest in patients with severe/critical COVID-19 and kidney dysfunction. Among all lymphocyte subset parameters, Th cell count was the most significant indicator for outcomes. ROC of the combined model of Th cell count and eGFR presented better predictive value than that of the other parameters. Th cell count <394.5 cells/μl and eGFR <87.5 ml/min/1·73m were independently associated with poor outcomes. The propensity score matching analysis revealed consistent results.

CONCLUSIONS

Reduced Th cell count and eGFR may be applied as promising predictive indicators for identifying COVID-19 patients with high risk and poor outcomes.

摘要

背景

关于伴有和不伴有肾功能损害的 COVID-19 患者淋巴细胞亚群的特征及其与患者结局的关系,目前知之甚少。

方法

比较了伴有或不伴有肾功能障碍的 COVID-19 患者的淋巴细胞亚群。主要结局是全因死亡率或重症监护病房(ICU)入院的复合结局。次要结局包括病毒脱落持续时间、住院时间和急性肾损伤。

结果

在严重/危重症 COVID-19 合并肾功能障碍的患者中,淋巴细胞亚群细胞计数最低。在所有淋巴细胞亚群参数中,Th 细胞计数是对结局最有意义的指标。Th 细胞计数和 eGFR 联合模型的 ROC 呈现出比其他参数更好的预测价值。Th 细胞计数 <394.5 个/μl 和 eGFR <87.5 ml/min/1·73m 与不良结局独立相关。倾向评分匹配分析得出了一致的结果。

结论

Th 细胞计数和 eGFR 降低可作为识别 COVID-19 高危和预后不良患者的有前途的预测指标。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f58/9938757/1b145dca6c55/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f58/9938757/ae51917d2a58/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f58/9938757/1b145dca6c55/gr5_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f58/9938757/ae51917d2a58/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f58/9938757/1b145dca6c55/gr5_lrg.jpg

相似文献

1
Adaptive immune dysfunction in patients with COVID-19 and impaired kidney function during the omicron surge.奥密克戎变异株流行期间合并 COVID-19 的患者适应性免疫功能障碍和肾功能受损。
Clin Immunol. 2023 Mar;248:109271. doi: 10.1016/j.clim.2023.109271. Epub 2023 Feb 18.
2
The characteristics and predictive role of lymphocyte subsets in COVID-19 patients.淋巴细胞亚群在 COVID-19 患者中的特征和预测作用。
Int J Infect Dis. 2020 Oct;99:92-99. doi: 10.1016/j.ijid.2020.06.079. Epub 2020 Aug 3.
3
Lymphocyte subsets as a predictor of severity and prognosis in COVID-19 patients.淋巴细胞亚群作为 COVID-19 患者严重程度和预后的预测指标。
Int J Immunopathol Pharmacol. 2021 Jan-Dec;35:20587384211048567. doi: 10.1177/20587384211048567.
4
Early reduction of estimated Glomerular Filtration Rate (eGFR) predicts poor outcome in acutely ill hospitalized COVID-19 patients firstly admitted to medical regular wards (eGFR-COV19 study).在最初收治于普通病房的急性发病住院 COVID-19 患者中,估算肾小球滤过率(eGFR)的早期降低预示着不良预后(eGFR-COV19 研究)。
Biomed Pharmacother. 2022 Sep;153:113454. doi: 10.1016/j.biopha.2022.113454. Epub 2022 Jul 21.
5
Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.评估 COVID-19 患者的 SARS-CoV-2 RNA 水平和淋巴细胞/T 细胞计数表明,初始免疫状态是疾病严重程度的主要决定因素。
Med Microbiol Immunol. 2020 Dec;209(6):657-668. doi: 10.1007/s00430-020-00693-z. Epub 2020 Aug 28.
6
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
7
The predictive role of lymphocyte subsets and laboratory measurements in COVID-19 disease: a retrospective study.淋巴细胞亚群和实验室检测在 COVID-19 疾病中的预测作用:一项回顾性研究。
Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211049739. doi: 10.1177/17534666211049739.
8
Iron metabolism and lymphocyte characterisation during Covid-19 infection in ICU patients: an observational cohort study.铁代谢和 ICU 患者 COVID-19 感染期间的淋巴细胞特征:一项观察性队列研究。
World J Emerg Surg. 2020 Jun 30;15(1):41. doi: 10.1186/s13017-020-00323-2.
9
Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China.新冠肺炎患者中受抑制的 T 细胞介导的免疫:来自中国武汉的临床回顾性研究。
J Infect. 2020 Jul;81(1):e51-e60. doi: 10.1016/j.jinf.2020.04.012. Epub 2020 Apr 18.
10
Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.伴有确诊的 2019 冠状病毒病(COVID-19)感染住院患者肾素-血管紧张素-醛固酮系统阻滞剂管理(麦吉尔 RAAS-COVID-19):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):115. doi: 10.1186/s13063-021-05080-4.

引用本文的文献

1
Global geographic and socioeconomic disparities in COVID-associated acute kidney injury: a systematic review and meta-analysis.新冠相关急性肾损伤的全球地理和社会经济差异:一项系统综述和荟萃分析。
J Glob Health. 2025 Jul 25;15:04166. doi: 10.7189/jogh.15.04166.
2
Immunophenotyping characteristics and clinical outcome of COVID-19 patients treated with azvudine during the Omicron surge.奥密克戎毒株流行期间接受阿兹夫定治疗的新冠患者的免疫表型特征及临床结局
Front Immunol. 2024 Nov 25;15:1465238. doi: 10.3389/fimmu.2024.1465238. eCollection 2024.
3
Deciphering the molecular nexus between Omicron infection and acute kidney injury: a bioinformatics approach.
解析奥密克戎感染与急性肾损伤之间的分子联系:一种生物信息学方法。
Front Mol Biosci. 2024 Jul 4;11:1340611. doi: 10.3389/fmolb.2024.1340611. eCollection 2024.
4
Immunophenotyping characteristics and outcome of COVID-19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir.新型冠状病毒肺炎患者的免疫表型特征和预后:外周血 CD8+T 细胞作为奈玛特韦治疗患者的预后生物标志物。
Front Immunol. 2023 Sep 20;14:1227905. doi: 10.3389/fimmu.2023.1227905. eCollection 2023.